Mesna
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Mock data
Subscribe for the real data
Subscribe for the real data
Commercial
No data
Clinical
Clinical Trials
759 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Lymphoma | D008223 | — | C85.9 | 55 | 148 | 36 | 8 | 12 | 232 |
| Sarcoma | D012509 | — | — | 23 | 73 | 37 | 3 | 18 | 141 |
| Leukemia | D007938 | — | C95 | 33 | 59 | 17 | 3 | 6 | 104 |
| Non-hodgkin lymphoma | D008228 | — | C85.9 | 23 | 56 | 17 | 3 | 4 | 85 |
| Precursor cell lymphoblastic leukemia-lymphoma | D054198 | — | C91.0 | 17 | 37 | 17 | 5 | 3 | 70 |
| B-cell lymphoma | D016393 | — | — | 20 | 38 | 9 | 1 | 3 | 60 |
| Large b-cell lymphoma diffuse | D016403 | — | C83.3 | 18 | 36 | 6 | 1 | 3 | 56 |
| Lymphoid leukemia | D007945 | — | C91 | 13 | 27 | 12 | 4 | 1 | 50 |
| Germ cell and embryonal neoplasms | D009373 | — | — | 9 | 30 | 7 | 2 | 3 | 43 |
| T-cell lymphoma | D016399 | — | — | 6 | 19 | 2 | 4 | — | 29 |
Show 18 more
Indications Phases 3
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Neoplasms | D009369 | — | C80 | 41 | 42 | 9 | — | 5 | 80 |
| Osteosarcoma | D012516 | — | — | 13 | 26 | 8 | — | 7 | 46 |
| Hodgkin disease | D006689 | — | C81 | 13 | 27 | 9 | — | 4 | 43 |
| Recurrence | D012008 | — | — | 12 | 20 | 3 | — | 1 | 30 |
| Neuroblastoma | D009447 | EFO_0000621 | — | 10 | 13 | 4 | — | 3 | 28 |
| Ewing sarcoma | D012512 | EFO_0000173 | — | 4 | 13 | 7 | — | 5 | 27 |
| Ovarian neoplasms | D010051 | EFO_0003893 | C56 | 10 | 19 | 5 | — | — | 27 |
| Breast neoplasms | D001943 | EFO_0003869 | C50 | 9 | 20 | 2 | — | — | 24 |
| Myelodysplastic syndromes | D009190 | — | D46 | 10 | 16 | 1 | — | 2 | 24 |
| Myeloid leukemia acute | D015470 | — | C92.0 | 10 | 14 | 1 | — | 1 | 23 |
Show 89 more
Indications Phases 2
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Hematologic neoplasms | D019337 | — | — | 12 | 18 | — | — | 1 | 23 |
| Melanoma | D008545 | — | — | 9 | 15 | — | — | 1 | 22 |
| Syndrome | D013577 | — | — | 4 | 11 | — | — | 1 | 12 |
| B-cell chronic lymphocytic leukemia | D015451 | — | C91.1 | 3 | 10 | — | — | — | 11 |
| Bcr-abl positive chronic myelogenous leukemia | D015464 | EFO_0000340 | — | 1 | 10 | — | — | — | 10 |
| Mantle-cell lymphoma | D020522 | — | C83.1 | 4 | 8 | — | — | — | 9 |
| Pancreatic neoplasms | D010190 | EFO_0003860 | C25 | 5 | 8 | — | — | — | 9 |
| Myelomonocytic leukemia juvenile | D054429 | — | C93.3 | 3 | 7 | — | — | — | 8 |
| Extranodal nk-t-cell lymphoma | D054391 | — | C86.0 | 2 | 7 | — | — | — | 8 |
| Urinary bladder neoplasms | D001749 | — | C67 | 2 | 7 | — | — | — | 7 |
Show 158 more
Indications Phases 1
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Rhabdoid tumor | D018335 | — | — | 1 | — | — | — | 1 | 2 |
| Ganglioneuroblastoma | D018305 | — | — | 1 | — | — | — | — | 1 |
| Intestinal diseases | D007410 | — | K63.9 | 1 | — | — | — | — | 1 |
| Thymoma | D013945 | — | — | 1 | — | — | — | — | 1 |
| Metabolic syndrome | D024821 | EFO_0000195 | E88.810 | 1 | — | — | — | — | 1 |
| Vasculitis | D014657 | EFO_0006803 | M31 | 1 | — | — | — | — | 1 |
| Myositis | D009220 | EFO_0000783 | G72.49 | 1 | — | — | — | — | 1 |
| Muscular diseases | D009135 | EFO_0002970 | G72.9 | 1 | — | — | — | — | 1 |
| Neuroepithelial neoplasms | D018302 | — | — | 1 | — | — | — | — | 1 |
| Obesity | D009765 | EFO_0001073 | E66.9 | 1 | — | — | — | — | 1 |
Show 11 more
Indications Without Phase
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Hemoglobinopathies | D006453 | — | D58.2 | — | — | — | — | 2 | 2 |
| Pituitary diseases | D010900 | — | E23.7 | — | — | — | — | 2 | 2 |
| Histiocytosis | D015614 | HP_0100727 | — | — | — | — | — | 1 | 1 |
| Langerhans-cell histiocytosis | D006646 | — | C96.6 | — | — | — | — | 1 | 1 |
| Wiskott-aldrich syndrome | D014923 | EFO_0003903 | D82.0 | — | — | — | — | 1 | 1 |
| Severe combined immunodeficiency | D016511 | — | D81.0 | — | — | — | — | 1 | 1 |
| Hemophagocytic lymphohistiocytosis | D051359 | — | D76.1 | — | — | — | — | 1 | 1 |
| Chronic granulomatous disease | D006105 | EFO_0000338 | D71 | — | — | — | — | 1 | 1 |
| Type 1 hyper-igm immunodeficiency syndrome | D053307 | — | — | — | — | — | — | 1 | 1 |
| Chediak-higashi syndrome | D002609 | Orphanet_167 | D72.0 | — | — | — | — | 1 | 1 |
Show 23 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
No data
Target
No data
Variants
No data
Financial
No data
Trends
No data
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
Subscribe for the real data
6,830 adverse events reported
View more details
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use